Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Colon Cancer treatment details. Biologic therapy. Chemotherapy. Hopital Tenon, Paris, France



Survival: 15.8 months
   
Toxicity Grade: 4
   
Treatments: Biologic therapy
Chemotherapy
   
Drugs: Adrucil
Eloxatin
Country: France
   
City/State/Province: Paris
   
Hospital: Hopital Tenon
   
Journal: Link
   
Date: 1/2007

Description:
Patients: This phase II study involved 42 patients with metastatic colorectal cancer. Twenty-four were men and 18 were women, and the median age was 60, ranging from 31-76. 67% had stage IV disease.

Treatment: All 42 patients received celecoxib (a non-steroidal anti-inflammatory drug) and the chemotherapy drugs 5FU (Fluorouracil) and oxaliplatin, and folinic acid.

Toxicity: There were two episodes of grade 4 toxicity; vomiting and thrombocytopenia. Grade 3 toxicities reported were nausea, diarrhea, peripheral neuropathy, neutropenia and thrombocytopenia.

Results: Median overall survival was 15.8 months. Thirty-five patients stopped the study for progression, toxicity, personal choice, or the investigator’s decision

Support: This study was supported by a grant from Pfizer. Pfizer makes celecoxib and markets it as Celebrex®

Correspondence: Dr. T. Andre

E-mail to a Friend Email Physician More Information